Updated Version Available-All About Darzalex/Darzalex Faspro (daratumumab) for Multiple Myeloma

What is Darzalex, and why is it such a game-changer in multiple myeloma treatment? In this HealthTree University lesson, we take a deep dive into Darzalex (daratumumab)—a monoclonal antibody that targets CD38 on myeloma cells. Whether given alone or in combination with other therapies, Darzalex has transformed outcomes for many patients with newly diagnosed or relapsed myeloma.

🔍 What you’ll learn:

What is Darzalex and how does it work?

IV vs. SubQ: Understanding the different ways Darzalex is given

How Darzalex is used in both newly diagnosed and relapsed settings

Common combinations: Darzalex with Revlimid, Velcade, dexamethasone, and more

Side effects to watch for—including infusion-related reactions

What patients say about their experience on Darzalex

How Darzalex fits into long-term treatment and maintenance

This video is for patients, caregivers, and anyone looking to better understand how this powerful targeted therapy is changing the treatment landscape for multiple myeloma.

#Darzalex #Daratumumab #MultipleMyeloma #MyelomaTreatment #CD38 #TargetedTherapy #BloodCancer #MyelomaAwareness #MyelomaCare #MyelomaEducation #RelapsedMyeloma #NewlyDiagnosedMyeloma #SubQDaratumumab #MonoclonalAntibody


Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so...

Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.